Dr. Boyle receives NCI R21 IMAT award!

Grants 

Dr. Boyle receives a NCI R21. This 3-year award focuses on technology development around identifying silencer elements in cancers as part of the broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.